Translational Assessment of Safety Profile (Cytokine Release) of Therapeutics in Humanized Mouse Models

• GenO-BRGSF-HIS recapitulate key CRS features induced by biologics tested in the clinic
• Immune cells are recruited, polarized and activated into the tumor microenvironment in genO-BRGSF-HIS
• GenO-BRGSF-HIS enables assessment of both efficacy and safety in a single model

Speakers:

Kader Thiam

Senior Vice President & Chief Scientific Officer, Discovery, Preclinical Models & Services

GenOway